Search Results - "Schwencke, Carsten"

Refine Results
  1. 1

    TCT-506 Two-Year Outcomes After Bioresorbable Scaffold Implantation– The Multicenter ASSURE Registry by Schwencke, Carsten, Naber, Christoph, Wöhrle, Jochen, Schmitz, Thomas, Frey, Norbert, Butter, Christian, Brachmann, Johannes, Mathey, Detlef

    “…Background In the ASSURE registry, the treatment of de-novo coronary artery lesions in a real world setting with everolimus-eluting bioresorbable scaffolds…”
    Get full text
    Journal Article
  2. 2

    Caveolin-1 Facilitates Mechanosensitive Protein Kinase B (Akt) Signaling In Vitro and In Vivo by Sedding, Daniel G, Hermsen, Jennifer, Seay, Ulrike, Eickelberg, Oliver, Kummer, Wolfgang, Schwencke, Carsten, Strasser, Ruth H, Tillmanns, Harald, Braun-Dullaeus, Ruediger C

    Published in Circulation research (01-04-2005)
    “…Mechanotransduction represents an integral part of vascular homeostasis and contributes to vascular lesion formation. Previously, we demonstrated a…”
    Get full text
    Journal Article
  3. 3

    Caveolin Is an Activator of Insulin Receptor Signaling by Yamamoto, Manabu, Toya, Yoshiyuki, Schwencke, Carsten, Lisanti, Michael P., Myers, Martin G., Ishikawa, Yoshihiro

    Published in The Journal of biological chemistry (09-10-1998)
    “…Recent data have demonstrated that caveolin, a major structural protein of caveolae, negatively regulates signaling molecules localized to caveolae. The…”
    Get full text
    Journal Article
  4. 4

    Chronic NOS inhibition prevents adverse lung remodeling and pulmonary arterial hypertension in caveolin-1 knockout mice by Wunderlich, Carsten, Schmeisser, Alexander, Heerwagen, Christian, Ebner, Bernd, Schober, Kristin, Braun-Dullaeus, Ruediger C, Schwencke, Carsten, Kasper, Michael, Morawietz, Henning, Strasser, Ruth H

    Published in Pulmonary pharmacology & therapeutics (01-01-2008)
    “…Abstract Recently generated caveolin-1 deficient mice (cav-1 ko) suffer from severe lung fibrosis with marked pulmonary hypertension and arterial hypoxemia and…”
    Get full text
    Journal Article
  5. 5

    Physicians' Radiation Exposure in the Catheterization Lab by Ingwersen, Maja, DVM, Drabik, Anna, PhD, Kulka, Ulrike, PhD, Oestreicher, Ursula, Dipl Biol, Fricke, Simon, BS, Krankenberg, Hans, MD, Schwencke, Carsten, MD, Mathey, Detlef, MD

    Published in JACC. Cardiovascular interventions (01-10-2013)
    “…Objectives This study sought to evaluate differences in radiation exposure of the operator depending on the type of catheterization lab procedure. Background…”
    Get full text
    Journal Article
  6. 6

    Inhibition of Adenylyl Cyclase by Caveolin Peptides by Toya, Yoshiyuki, Schwencke, Carsten, Couet, Jacques, Lisanti, Michael P., Ishikawa, Yoshihiro

    Published in Endocrinology (Philadelphia) (01-04-1998)
    “…Abstract Caveolae and their principal component caveolin have been implicated in playing a major role in G protein-mediated transmembrane signaling. We…”
    Get full text
    Journal Article
  7. 7

    Recanalization of chronic total coronary occlusions-high success rate despite a restrictive use of the retrograde approach by Bijuklic, Klaudija, Schwencke, Carsten, Schofer, Joachim

    “…Aim The retrograde approach in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is increasingly being used as a first‐line intervention…”
    Get full text
    Journal Article
  8. 8

    Ischemic preconditioning prevents ischemia-induced beta-adrenergic receptor sequestration by Iwatsubo, Kousaku, Toya, Yoshiyuki, Fujita, Takayuki, Ebina, Toshiaki, Schwencke, Carsten, Minamisawa, Susumu, Umemura, Satoshi, Ishikawa, Yoshihiro

    “…Preconditioning enables endogenous protection to repeated myocardial ischemia. However, the effect of preconditioning on beta1 adrenergic receptor (AR) signal…”
    Get full text
    Journal Article
  9. 9

    Long-term major adverse cardiac and cerebrovascular events (MACCE) rate: Comparison of retrograde and antegrade recanalization of chronic total coronary occlusions by Bijuklic, Klaudija, Schwencke, Carsten, Schofer, Joachim

    Published in Wiener Klinische Wochenschrift (01-04-2017)
    “…Summary Background The recanalization success rate of chronic total occlusion (CTO) percutaneous coronary interventions (PCI) can be increased by the…”
    Get full text
    Journal Article
  10. 10

    Physicians' radiation exposure in the catheterization lab: does the type of procedure matter? by Ingwersen, Maja, Drabik, Anna, Kulka, Ulrike, Oestreicher, Ursula, Fricke, Simon, Krankenberg, Hans, Schwencke, Carsten, Mathey, Detlef

    Published in JACC. Cardiovascular interventions (01-10-2013)
    “…This study sought to evaluate differences in radiation exposure of the operator depending on the type of catheterization lab procedure. Invasive cardiologists…”
    Get full text
    Journal Article
  11. 11

    TCT-193 Long-term follow up after antegrade versus retrograde recanalization of chronic total coronary occlusions by Bijuklic, Klaudija, Schwencke, Carsten, Schofer, Joachim

    “…Aim of the study was to evaluate the long-term MACCE rate (death, myocardial infarction, coronary bypass surgery and stroke) in patients after retrograde…”
    Get full text
    Journal Article
  12. 12

    Regulation of type V adenylyl cyclase by PMA-sensitive and -insensitive protein kinase C isoenzymes in intact cells by Kawabe, Jun-ichi, Ebina, Toshiaki, Toya, Yoshiyuki, Oka, Naoki, Schwencke, Carsten, Duzic, Emir, Ishikawa, Yoshihiro

    Published in FEBS letters (22-04-1996)
    “…Type V adenylyl cyclase (AC) was stably over-expressed in HEK293 cells (293AC-V). Forskolin-stimulated cAMP accumulation in 293AC-V was 5 times as great as…”
    Get full text
    Journal Article
  13. 13

    Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds by Wöhrle, Jochen, Naber, Christoph, Schmitz, Thomas, Schwencke, Carsten, Frey, Norbert, Butter, Christian, Brachmann, Johannes, Ingwersen, Maja, Drabik, Anna, Markovic, Sinisa, Mathey, Detlef G

    Published in EuroIntervention (01-06-2015)
    “…Bioresorbable vascular scaffolds (BVS) have been available on the European market since November 2011. The ASSURE registry aims to investigate the safety and…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Isoform-specific Regulation of Adenylyl Cyclase by Oxidized Catecholamines by Ebina, Toshiaki, Toya, Yoshiyuki, Oka, Naoki, Schwencke, Carsten, Kawabe, Jun-ichi, Ishikawa, Yoshihiro

    “…Both epinephrine and manganese are known to stimulate cAMP production in cardiac homogenates. When added together, however, they inhibited adenylyl cyclase…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Caveolin Interaction with Protein Kinase C by Oka, Naoki, Yamamoto, Manabu, Schwencke, Carsten, Kawabe, Jun-ichi, Ebina, Toshiaki, Ohno, Shigeo, Couet, Jacques, Lisanti, Michael P., Ishikawa, Yoshihiro

    Published in The Journal of biological chemistry (26-12-1997)
    “…Caveolar localization of protein kinase C and the regulation of caveolar function by protein kinase C are well known. This study was undertaken to examine…”
    Get full text
    Journal Article
  18. 18

    Endovascular Repair of Ascending Aortic Aneurysm by Transapical Approach and Periscope Technique by Krankenberg, Hans, Bader, Ralf, Sixt, Sebastian, Tübler, Thilo, Schwencke, Carsten, Kivelitz, Dietmar, Rad, Ashrat, Caspary, Michael, Zeller, Thomas

    Published in Journal of endovascular therapy (01-02-2013)
    “…Purpose To demonstrate transapical stent-graft implantation for the treatment of an ascending aortic aneurysm simultaneously using the “periscope” technique…”
    Get full text
    Journal Article
  19. 19

    Soluble Adenylyl Cyclase from Spodoptera frugiperda (Sf9) Cells by Kawabe, Jun-ichi, Toya, Yoshiyuki, Schwencke, Carsten, Oka, Naoki, Ebina, Toshiaki, Ishikawa, Yoshihiro

    Published in The Journal of biological chemistry (16-08-1996)
    “…An insect ovarian cell, Spodoptera frugiperda (Sf9), has been widely used to express recombinant proteins, including adenylyl cyclase, as a host cell in the…”
    Get full text
    Journal Article
  20. 20

    TCT-620 Twelve-Month Clinical Results After Bioresorbable Scaffolds – The ASSURE Registry by Naber, Christoph, Wöhrle, Jochen, Schmitz, Thomas, Schwencke, Carsten, Frey, Norbert, Butter, Christian, Brachmann, Johannes, Ingwersen, Maja, Drabik, Anna, Marcovic, Sinisa, Mathey, Detlef

    “…Acute gain of minimal lumen diameter was 1.54 ± 0.51 mm. Through 12 months, 1 patient (0,5%) died from gastrointestinal bleeding, 3 (1.7%) non-target vessel…”
    Get full text
    Journal Article